silybin has been researched along with Alcoholic Fatty Liver in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Jiang, T; Li, Y; Lu, Y; Xu, J | 1 |
Fehér, J; Lengyel, G | 1 |
Fedotova, TF; Trubitsina, IE | 1 |
1 review(s) available for silybin and Alcoholic Fatty Liver
Article | Year |
---|---|
[Silymarin in the treatment of chronic liver diseases: past and future].
Topics: Antioxidants; Carcinoma, Hepatocellular; Chronic Disease; Colorectal Neoplasms; Fatty Liver; Fatty Liver, Alcoholic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Oxidative Stress; Silybin; Silymarin; Survival Analysis; Treatment Outcome | 2008 |
2 other study(ies) available for silybin and Alcoholic Fatty Liver
Article | Year |
---|---|
Network Pharmacology Analysis and Experimental Validation to Explore the Anti-inflammatory Mechanism of Asiatic Acid on Alcoholic Steatohepatitis.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cholesterol; Eosine Yellowish-(YS); Ethanol; Fatty Liver, Alcoholic; Hematoxylin; Inflammation; Interleukin-1beta; Interleukin-6; Lipids; Liver; Mice; Network Pharmacology; NF-kappa B; Silybin; Tumor Necrosis Factor-alpha | 2022 |
[Hepatoprotectors in therapy of the alcoholic liver disease (clinical and experimental research)].
Topics: Adult; Aged; Animals; Antioxidants; Fatty Liver, Alcoholic; Female; Humans; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Experimental; Male; Middle Aged; Rats; Silybin; Silymarin | 2011 |